The Efficacy of Reduced-dose Dasatinib as a Subsequent...

Internal Medicine 2018 Vol. 57; Iss. 1

The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group

Iriyama, Noriyoshi, Ohashi, Kazuteru, Hashino, Satoshi, Kimura, Shinya, Nakaseko, Chiaki, Takano, Hina, Hino, Masayuki, Uchiyama, Michihiro, Morita, Satoshi, Sakamoto, Junichi, Sakamaki, Hisashi, Inok
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
57
Year:
2018
Language:
english
Journal:
Internal Medicine
DOI:
10.2169/internalmedicine.9035-17
File:
PDF, 285 KB
english, 2018
Conversion to is in progress
Conversion to is failed